Challenges in enhancing physical performance in thoracic cancer cachexia

Tateaki Naito, Tateaki Naito

No abstract available

Keywords: anamorelin; cachexia; multimodal intervention.

Conflict of interest statement

The author received a lecture fee from ONO Pharmaceutical Co. Ltd and research funding from Otsuka Pharmaceutical Co. Ltd. This work was supported by the Japan Agency for Medical Research and Development (AMED) under grant number 21ck0106673h0001.

References

    1. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980;69(4):491–7.
    1. Naito T. Evaluation of the true endpoint of clinical trials for cancer cachexia. Asia Pac J Oncol Nurs. 2019;6(3):227–33.
    1. Roeland EJ, Bohlke K, Baracos VE, Bruera E, Del Fabbro E, Dixon S, et al. Management of cancer cachexia: ASCO guideline. J Clin Oncol. 2020;38(21):2438–53.
    1. Oikawa SY, Brisbois TD, van Loon LJC, Rollo I. Eat like an athlete: insights of sports nutrition science to support active aging in healthy older adults. Geroscience. 2021. 10.1007/s11357-021-00419-w Epub ahead of print.
    1. Yoshimura Y, Wakabayashi H, Yamada M, Kim H, Harada A, Arai H. Interventions for treating sarcopenia: a systematic review and meta‐analysis of randomized controlled studies. J Am Med Dir Assoc. 2017;18(6):553.e1–553.e16.
    1. Fearon KC. Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer. 2008;44(8):1124–32.
    1. Grande AJ, Silva V, Sawaris Neto L, Teixeira Basmage JP, Peccin MS, Maddocks M. Exercise for cancer cachexia in adults. Cochrane Database Syst Rev. 2021;3(3):CD010804.
    1. Solheim TS, Laird BJA, Balstad TR, Stene GB, Bye A, Johns N, et al. A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer. J Cachexia Sarcopenia Muscle. 2017;8(5):778–88.
    1. Naito T, Mitsunaga S, Miura S, Tatematsu N, Inano T, Mouri T, et al. Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non‐small‐cell lung cancer. J Cachexia Sarcopenia Muscle. 2019;10(1):73–83.
    1. Miura S, Naito T, Mitsunaga S, Omae K, Mori K, Inano T, et al. A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non‐small cell lung or pancreatic cancer: the NEXTAC‐TWO study protocol. BMC Cancer. 2019;19(1):528.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する